Emerson Electric (EMR) FY2025 Earnings Quality Report

Grade: F — Receivables Outpacing Revenue Plus $7.2B AspenTech Buy-In

Framework: Schilit *Financial Shenanigans* + Beneish M-Score + forensic accounting principles

Data: SEC EDGAR 10-K (Filed 2025-11-10) + Yahoo Finance

Auditor: KPMG LLP — Clean opinion

One-line verdict: Emerson Electric closed out its multi-year portfolio transformation in FY2025 by spending another $7.2 billion in March 2025 to buy in the remaining AspenTech shares it didn't already own, completing a pivot that began with the Climate Technologies (Copeland) sale to Blackstone for $14.0 billion in 2023 and the $8.2 billion National Instruments acquisition later that year. The result is a smaller, higher-margin industrial technology business — FY2025 revenue of $18.0B on just 3% underlying growth, but gross margin expanded to 52.8% and adjusted EPS of $6.00. GAAP earnings from continuing operations of $2.29B look good — but the screening engine flags three problems: accounts receivable has outpaced revenue growth for two consecutive years (A2 fail), cash of $1.54B covers only 11% of $13.76B of debt (C4 fail) — debt that jumped $5.4B YoY to fund the AspenTech take-private — and goodwill plus intangibles of $27.7B now equals 136% of shareholders equity (D1 fail). The core business is real and high-margin, but Emerson has become a balance-sheet-leveraged roll-up disguised as an industrial automation leader.

The Numbers: Transformation Complete, Now Comes the Integration

Emerson's MD&A describes a company that "has taken significant actions to accelerate the transformation of its portfolio through the completion of strategic acquisitions and divestitures of non-core businesses. These actions were undertaken to create a cohesive, higher growth and higher margin industrial technology portfolio as a global automation leader."

Underlying sales growth was just 3% — "2.5 percent higher price and 0.5 percent higher volume." Volume growth of 0.5% is the headline to watch. Virtually all of the reported 3% came from pricing actions, not from actual unit demand. Intelligent Devices grew 2% and Software and Control grew 5%. International underlying sales were up just 1% — "China down 4 percent," "Europe decreased 2 percent," "Latin America was flat."

The gross margin expansion is real — up 2.0 percentage points to 52.8% — but the MD&A explains: "The prior year reflected the impact from acquisition-related inventory step-up amortization of $231, which negatively impacted margins by approximately 1.3 percentage points." So about two-thirds of the margin gain was the non-recurrence of the NI purchase-accounting hit.

The Portfolio Transformation, Summarized from the 10-K

The MD&A provides a clear list of the transactions:

The March 2025 AspenTech take-private is the key balance sheet event. Total debt went from $8.36B to $13.76B, an increase of $5.4B. Cash balance simultaneously fell from $3.59B to $1.54B. Net debt jumped roughly $7.5B — very close to the $7.2B AspenTech deal price.

The 10-K also flags the "Loss on Copeland note receivable" of $279M in 2024 — a reminder that even Emerson's "clean" divestitures have hair on them. The note was originally booked at a higher value, then adjusted to $1.9B to reflect the actual sale price.

Cash Flow: Strong on Its Own, But Priced In

The MD&A notes: "The Company generated operating cash flow from continuing operations of $3.7 billion in 2025, an increase of $359, or 11 percent, reflecting higher earnings and favorable changes in working capital." But the consolidated cash flow statement in Yahoo Finance shows total OCF of $3.10B (continuing + discontinued + other adjustments).

The 18-Point Screening

Revenue Quality

A2 is a red flag. Two consecutive years of accounts receivable growing faster than revenue is a classic Schilit early-warning indicator. AR went from ~$2.26B (FY2022) to $2.52B (FY2023) to $2.93B (FY2024) to $3.10B (FY2025). Revenue grew 9.9%, 15.3%, 3.0% over those same years — AR growth lagged in the jump year (2024) because of the NI acquisition comparison base, but the 2-year pattern still trips the flag.

A3 shows revenue +3% while CFFO declined 7%. The engine passes it because revenue growth is below the 10% threshold for an automatic fail, but the underlying pattern is the same as the A2 issue.

Expense Quality

No flags here. The margin expansion is documented and the cost base tracks revenue.

Cash Flow Quality

C4 is a red flag. Total debt jumped from $8.36B to $13.76B in FY2025 — a 65% increase — while cash fell from $3.59B to $1.54B. The cash-to-debt ratio dropped from 43% to 11%. This is entirely attributable to the AspenTech take-private financing. EMR raised debt and drew down cash to take AspenTech private.

Balance Sheet Health

D1 is a red flag. Goodwill of $18.19B plus other intangibles of $9.46B totals $27.65B against shareholders equity of $20.28B — 136%. This is the accumulated price of the transformation: NI brought $6.0B+ of goodwill in 2023, and the AspenTech take-private added more. The $20.28B equity itself is down from $21.64B a year ago — the $7.2B AspenTech payment was "reported as an adjustment to Equity" per the MD&A since it was a minority interest buyout, not a step-up acquisition.

The D2 leverage check passes at 2.8x Debt/EBITDA — but that is against a *trailing* EBITDA base that does not yet reflect a full year of the leveraged capital structure. The forward ratio will depend on AspenTech synergies materializing.

Acquisition Risk

E1 watch: free cash flow net of acquisitions has been negative in two of the last three years because of the $8.2B NI and $7.2B AspenTech deals. Emerson is funding roll-up M&A from a combination of divestiture proceeds, debt, and operating cash — not from operating cash alone.

E2 passes because the gross goodwill+intangibles number actually declined slightly year-over-year (from $28.5B to $27.65B, about -3%) due to amortization exceeding new acquisition goodwill additions — the AspenTech take-private was an equity transaction that did not add new goodwill (they already consolidated AspenTech; they just bought out the minority).

Beneish M-Score: -2.67 (Clean)

Comfortably clean. The Beneish formula does not catch serial-acquirer balance sheet stress — it catches operating manipulation, and Emerson is not manipulating operations.

Altman Z-Score: 4.48 (Safe)

Z-Score of 4.48 is comfortably in the safe zone. Emerson's fundamental industrial-automation profitability keeps this high despite the leverage. Working capital, retained earnings, and EBIT/assets all contribute positively.

Key Risks from the 10-K

1. Competitive Pressures Across All Segments

Item 1A opens: "We Operate in Businesses That Are Subject to Competitive Pressures That Could Affect Prices or Demand for Our Products. Our businesses operate in markets that are highly competitive and potentially volatile, and we compete on the basis of product performance, quality, service and/or price across the industries and markets served." Emerson explicitly notes "some of our competitors have substantially greater sales, assets and financial resources than our Company." The process automation business faces Siemens, ABB, Schneider Electric, Rockwell, Honeywell — all with similar scale.

2. Innovation Treadmill for AI/Automation

The 10-K flags: "Our Operating Results Depend in Part on Continued Successful Research, Development and Marketing of New and/or Improved Products and Services… Our businesses are affected by varying degrees of technological change, such as, among others, artificial intelligences and machine learning, and corresponding shifts in customer demand." The whole AspenTech thesis is that industrial AI/asset optimization software is the next growth engine. If competitors deliver comparable software at lower prices, the $7.2B price Emerson paid to buy in AspenTech becomes hard to justify.

3. Decarbonization Technology Bets

Item 1A states: "Market growth from the use of cleaner energy sources, as well as emissions management, energy efficiency and decarbonization efforts are likely to depend in part on technologies not yet deployed or widely adopted today. We may not adequately innovate or position our businesses for the adoption of technologies such as battery storage solutions, hydrogen use cases in industry, mobility, and power generation, enhanced electrical grid demand management, carbon capture and sequestration or advanced nuclear power." Emerson is exposed to process industry capital cycles — oil & gas, chemicals, power — and the transition trajectory for each of those is uncertain.

4. AspenTech Integration and Synergy Realization

The AspenTech deal closed March 12, 2025 — meaning FY2025 results include only ~6.5 months of the fully-consolidated entity. The thesis requires synergies in go-to-market and product development that are not yet in the numbers. The $7.2B purchase price (for the remaining stake) implies an enterprise value of roughly $14B+ for AspenTech — a premium valuation that requires successful integration to earn back.

5. Volume Growth of Only 0.5%

The MD&A's own number: "Underlying sales were up 3 percent on 2.5 percent higher price and 0.5 percent higher volume." Almost all the reported 3% growth came from price hikes, not from actual unit demand. Price increases beyond a point can squeeze customers and invite market-share loss. Competitors with cheaper products can take volume if Emerson holds the price line.

6. Leverage Tied to a Bet

The $13.76B of debt financed an industrial technology roll-up. If the automation industry slows or synergies underdeliver, Emerson cannot easily deleverage without cutting into the dividend (which has been paid annually for 69+ consecutive years). The refinancing schedule is not shown in the section read, but the 65% jump in debt this year alone suggests material near-term maturities.

7. China Exposure

"China down 4 percent" in 2025. The MD&A does not disclose China as a percentage of total, but for a process automation company it is material. Geopolitical friction and Chinese domestic automation competitors (Inovance, Delta) are structural headwinds.

Summary

Emerson Electric's FY2025 10-K shows a company at the end of a multi-year portfolio transformation. Revenue of $18.0B with just 0.5% volume growth is the new baseline. Gross margin expanded to 52.8% and adjusted EPS reached $6.00, both records for the reshaped portfolio.

Three red flags:

Plus one watch: E1 — FCF net of acquisitions negative in 2 of last 3 years.

Things working: M-Score -2.67 (clean), Altman Z-Score 4.48 (safe), gross margin expansion is real, SG&A discipline delivered 1.1pp leverage, $2.67B of free cash flow, dividend maintained. The core industrial automation business is structurally attractive.

Things to watch: Only 0.5% volume growth (price doing all the work), the AspenTech integration thesis is still unproven, China revenue declining, $13.76B of debt on a business that just finished a capital-hungry transformation.

Bottom line: Emerson has completed a transformation to become a higher-margin, software-heavy industrial automation company — but has done so by loading up on debt and goodwill. The F grade here is not an accusation of manipulation (the M-Score is clean at -2.67) — it is a mechanical result of three structural balance-sheet flags. Investors convinced that AspenTech synergies will materialize and that industrial AI automation is a durable growth market will look past these; investors requiring balance-sheet strength in addition to operating quality will not.

**Disclaimer**: This report is based on Emerson Electric's FY2025 10-K (SEC EDGAR) and public financial data. It uses forensic accounting screening frameworks (Schilit's *Financial Shenanigans*, Beneish M-Score, Altman Z-Score) for red flag detection. This is NOT investment advice. Screening for red flags does not constitute a buy or sell recommendation. Past financial performance does not predict future results. Always do your own research and consult a qualified financial advisor.

**About EarningsGrade**: We screen earnings reports to help investors identify financial red flags. Our approach: "Screen out, not screen in." A passing grade means no red flags were detected — it does not mean the stock is a good investment.